ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,423Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 113

$578K Total Retail Price of All Prescriptions

Rank: 20 out of 113

461 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 461 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 461 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 9,944 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 751 655 1 2
LEVOTHYROXINE SODIUM 680 602 2 1
LISINOPRIL 467 426 3 3
OMEPRAZOLE 377 305 4 5
AMLODIPINE BESYLATE 351 337 5 4
HYDROCHLOROTHIAZIDE 338 294 6 9
WARFARIN SODIUM 276 251 7 8
ATORVASTATIN CALCIUM 276 253 7 15
LOSARTAN POTASSIUM 256 250 9 13
CHLORTHALIDONE 227 208 10 78
POTASSIUM CHLORIDE 226 202 11 12
METOPROLOL SUCCINATE 199 179 12 10
METFORMIN HCL 199 168 12 11
METFORMIN HCL ER 168 136 14 51
CITALOPRAM HBR 165 143 15 17
CYMBALTA 163 139 16 37
FUROSEMIDE 160 154 17 6
HYDROCODONE-ACETAMINOPHEN 145 115 S3 18 7
ALLOPURINOL 133 122 19 20
ALENDRONATE SODIUM 130 121 20 22
TRAMADOL HCL 129 119 21 29
ATENOLOL 128 113 22 16
TAMSULOSIN HCL 127 127 23 24
METOPROLOL TARTRATE 125 125 24 14
LOSARTAN-HYDROCHLOROTHIAZIDE 124 122 25 40
ZOLPIDEM TARTRATE 123 103 26 19
FLUOXETINE HCL 120 101 27 31
CRESTOR 118 109 28 30
PRAVASTATIN SODIUM 110 97 29 23
SPIRONOLACTONE 107 99 30 32
CARVEDILOL 101 83 31 25
DIOVAN 94 62 32 42
TRAZODONE HCL 89 84 33 41
PAROXETINE HCL 80 52 34 45
GLIMEPIRIDE 80 69 34 36
DONEPEZIL HCL 71 71 36 33
TRIAMTERENE-HCTZ 69 65 37 26
GABAPENTIN 69 46 37 18
HUMALOG 68 43 39 70
DIGOXIN 68 65 39 27
PROPRANOLOL HCL 67 67 41 92
FLUTICASONE PROPIONATE 63 50 42 39
AMITRIPTYLINE HCL 56 49 R 43 58
CARBIDOPA-LEVODOPA 53 44 44 73
SERTRALINE HCL 53 35 44 21
ROPINIROLE HCL 50 50 46 67
RAMIPRIL 50 39 46 116
LANTUS 50 35 46 38
OXYBUTYNIN CHLORIDE ER 50 50 46 112
PLAVIX 50 50 46 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.